| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
Piclozotan manufacturers
- Piclozotan
-
- $1520.00
-
2026-07-27
- CAS:182415-09-4
- Purity: 98.59%
- Supply Ability: 10g
|
| | Piclozotan Basic information |
| Product Name: | Piclozotan | | Synonyms: | Piclozotan;5-Hydroxy Saxagliptin Hydrochloride;1,4-Benzoxazepin-5(4H)-one, 3-chloro-4-[4-(3',6'-dihydro[2,4'-bipyridin]-1'(2'H)-yl)butyl]-;Piclozotan (anhydrous);SUN4057;SUN-4057;SUNN4057;SUN-N-4057 | | CAS: | 182415-09-4 | | MF: | C23H24ClN3O2 | | MW: | 409.91 | | EINECS: | | | Product Categories: | | | Mol File: | 182415-09-4.mol |  |
| | Piclozotan Chemical Properties |
| | Piclozotan Usage And Synthesis |
| Uses | Piclozotan (SUN N4057) is a 5HT1A receptor agonist. Piclozotan improves motor complications in Parkinson's disease model[1]. | | IC 50 | 5-HT1A Receptor | | References | [1] Tani Y, et al. Effects of piclozotan (SUN N4057), a partial serotonin 1A receptor agonist, on motor complications induced by repeated administration of levodopa in parkinsonian rats. Eur J Pharmacol. 2010 Dec 15;649(1-3):218-23. DOI:10.1016/j.ejphar.2010.09.013
[2] AIYING WANG. Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.[J]. BMC Pharmacology & Toxicology, 2012, 12: 2. DOI: 10.1186/1471-2210-12-2 |
| | Piclozotan Preparation Products And Raw materials |
|